Furthermore, in vivo experiments validated the in vitro findings and further confirmed that AKR1B1 plays a pivotal role in the glutathione regulatory pathway in drug-resistant HCC cells (Supplementary Fig. 33). Here, AKR1B1 is linked to hepatocellular carcinoma.